| Marksans Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524404 |
NSE Symbol : MARKSANS |
P/E(TTM) : 44.25 |
|
ISIN Demat : INE750C01026 |
Div & Yield% : 0.29 |
EPS(TTM) : 7.10 |
|
Book Value(₹) : 36.46 |
Market Cap(₹Cr) : 14,236.14 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 321.19 | 361.57 | 339.73 | 320.44 | 319.73 | 299.36 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 321.19 | 361.57 | 339.73 | 320.44 | 319.73 | 299.36 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 17.47 | 27.48 | 15.86 | 58.19 | 2.01 | 6.64 |
| Total Income | 338.66 | 389.05 | 355.59 | 378.63 | 321.74 | 305.99 |
| Total Expenditure | 239.08 | 255.58 | 264.28 | 248.37 | 249.68 | 247.60 |
| PBIDT | 99.57 | 133.47 | 91.30 | 130.26 | 72.06 | 58.39 |
| Interest | 0.34 | 0.35 | 0.36 | 0.32 | 0.30 | 0.31 |
| PBDT | 99.23 | 133.11 | 90.95 | 129.95 | 71.76 | 58.08 |
| Depreciation | 8.78 | 8.76 | 8.83 | 8.46 | 8.19 | 8.18 |
| Tax | 21.38 | 30.11 | 20.84 | 20.81 | 14.54 | 11.56 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.04 | 2.33 | 0.37 | 0.88 | 0.98 | 0.75 |
| Reported Profit After Tax | 69.04 | 91.92 | 60.91 | 99.81 | 48.06 | 37.59 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 69.04 | 91.92 | 60.91 | 99.81 | 48.06 | 37.59 |
| EPS (Unit Curr.) | 1.52 | 2.03 | 1.34 | 2.20 | 1.06 | 0.83 |
| EPS (Adj) (Unit Curr.) | 1.52 | 2.03 | 1.34 | 2.20 | 1.06 | 0.83 |
| Calculated EPS (Unit Curr.) | 1.52 | 2.03 | 1.34 | 2.20 | 1.06 | 0.83 |
| Calculated EPS (Adj) (Unit Curr.) | 1.52 | 2.03 | 1.34 | 2.20 | 1.06 | 0.83 |
| Calculated EPS (Ann.) (Unit Curr.) | 6.09 | 8.11 | 5.38 | 8.81 | 4.24 | 3.32 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 6.09 | 8.11 | 5.38 | 8.81 | 4.24 | 3.32 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 45.32 | 45.32 | 45.32 | 45.32 | 45.32 | 45.32 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 31.00 | 36.91 | 26.87 | 40.65 | 22.54 | 19.50 |
| PBDTM(%) | 30.89 | 36.81 | 26.77 | 40.55 | 22.44 | 19.40 |
| PATM(%) | 21.50 | 25.42 | 17.93 | 31.15 | 15.03 | 12.56 |
